EarningsQ4 2023 Earnings Report

Altimmune (ALT1) Q4 2023 Earnings Report

0 Followers

MX:ALT1 Q4 2023 EPS Results

Actual EPS-$9.76

Consensus EPS-$8.22

Beat/MissMissed by -$1.54

One Year Ago EPS-$7.77

Actual Revenue$668.71K

Expected Revenue$36.15K

Beat/MissBeat by +$632.57K

YoY Revenue Growth+133.64%

QuarterQ4 2023

Date03/27/2024

TimeBefore Open

Conference CallWednesday, March 27, 2024

MX:ALT1 Upcoming Earnings

Altimmune's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

MX:ALT1 Q4 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-2.39 / -	-3.795	―
Aug 12, 2026	2026 (Q2)	-2.49 / -2.17	-4.88	55.56% (+2.71)
May 13, 2026	2026 (Q1)	-4.37 / -3.25	-4.699	30.77% (+1.45)
Mar 05, 2026	2025 (Q4)	-4.30 / -4.88	-5.964	18.18% (+1.08)
Nov 06, 2025	2025 (Q3)	-4.92 / -3.80	-5.783	34.38% (+1.99)
Aug 12, 2025	2025 (Q2)	-6.07 / -4.88	-6.326	22.86% (+1.45)
May 13, 2025	2025 (Q1)	-6.36 / -4.70	-6.145	23.53% (+1.45)
Feb 27, 2025	2024 (Q4)	-6.00 / -5.96	-9.76	38.89% (+3.80)
Nov 12, 2024	2024 (Q3)	-6.45 / -5.78	-7.049	17.95% (+1.27)
Aug 08, 2024	2024 (Q2)	-6.31 / -6.33	-5.783	-9.37% (-0.54)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed